Anti-HIV imidazolone derivatives
US6518293B2 · kind B2 · utility
0Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2001 |
| Grant date | Feb 11, 2003 |
| Priority date | — |
| Expiry date | Nov 6, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/86
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is concerned with novel imidazolone derivatives, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents against HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.